• Rm 77.139, 23 Innovation Walk, Monash University

    3800 Clayton


If you made any changes in Pure these will be visible here soon.

Personal profile


Dr. Kylie M, Ph.D, is a National Breast Cancer Foundation Career Development Fellow within the Department of Biochemistry and Mol. Biology, at Monash University (Clayton, Melbourne, Australia) and Head of the Cancer Targeting and Nuclear Therapeutics Laboratory. She got her B.Biomed.Sci.and her Ph.D.in Biochemistry at Monash University (Melbourne). Her research over the last 18 years has focused on the regulation of transport into and out of the eukaryotic cell nucleus, and how this relates to viral disease, cancer and development. She has c. 40 peer-reviewed publications (>1,000 citations; H-factor of 18). Her awards and prizes include National Breast Cancer Foundation, Career Development Fellowship(2017), the International Union of Biochemistry and Molecular Biology (IUBMB) Young Scientist Program Prize (2009) and the Caroline Chisholm award for service (2015).

Research interests

Transport of proteins between the cytoplasm and nucleus and the application of this to diseases including cancer and viral infection.


  • Nuclear Transport
  • Drug development
  • anti-viral drugs
  • Cell Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2019

Selected Research Output 2005 2018

  • 43 Article
  • 2 Chapter (Book)
  • 1 Encyclopaedia / Dictionary Entry
  • 1 Comment / Debate

Ivermectin is a specific inhibitor of importin alpha/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus

Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D. & Jans, D. A., 2012, In : Biochemical Journal. 443, 3, p. 851 - 856 6 p.

Research output: Contribution to journalArticleResearchpeer-review